Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Hardy

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Diabetes, Obesity & Metabolism|October 1, 2021
Ultra rapid lispro (URLi) shows accelerated pharmacokinetics and greater reduction in postprandial glucose versus Humalog® in patients with type 1 diabetes mellitus in a randomized, double-blind meal test early-phase studyChristof Kazda, Jennifer Leohr, Rong Liu, et al.
Therapeutic Advances in Neurological Disorders|September 18, 2023
A 20-year multicentre retrospective review of optic nerve sheath fenestration outcomesShaddy El-Masri, Matthew Wilson, Jonathan Goh, et al.
American Journal of Obstetrics & Gynecology MFM|July 12, 2022
Latency of late preterm steroid administration to delivery and risk of neonatal hypoglycemiaEliza R McElwee, Kyla Wilkinson, Rebecca Crowe, et al.
Orbit (Amsterdam, Netherlands)|August 12, 2025
Orbital abscess secondary to acute dacryocystitisJosefina Herrera, Sophia Moshegov, Deepaysh Charanjeet, et al.
Diabetes, Obesity & Metabolism|March 9, 2021
Improved postprandial glucose control with ultra rapid lispro versus lispro with continuous subcutaneous insulin infusion in type 1 diabetes: PRONTO-Pump-2Mark Warren, Bruce Bode, Jang I Cho, et al.
Sensors (Basel, Switzerland)|July 12, 2025
Wavelet-Based P-Wave Detection in High-Rate GNSS Data: A Novel Approach for Rapid Earthquake Monitoring in Tsunamigenic SettingsAjat Sudrajat, Irwan Meilano, Hasanuddin Z Abidin, et al.
Children (Basel, Switzerland)|October 23, 2021
Dexamethasone Alters Tracheal Aspirate T-Cell Cytokine Production in Ventilated Preterm InfantsSiamak M Yazdi, Ekta U Patel, Colby D Richardson, et al.
Diabetes, Obesity & Metabolism|October 10, 2023
Ultra rapid lispro (Lyumjev®) shortens time to recovery from hyperglycaemia compared to Humalog® in individuals with type 1 diabetes on continuous subcutaneous insulin infusionJennifer Leohr, Mary Anne Dellva, Elizabeth LaBell, et al.
Diabetes, Obesity & Metabolism|October 4, 2021
Ultra-rapid lispro shows faster pharmacokinetics and reduces postprandial glucose excursions versus Humalog® in patients with type 2 diabetes mellitus in a randomized, controlled crossover meal test early phase studyJennifer Leohr, Christof Kazda, Rong Liu, et al.
Clinical Therapeutics|July 25, 2006
A double-blind, randomized trial to evaluate the pharmacokinetics and tolerability of 30 or 40 mg/d oral olanzapine relative to 20 mg/d oral olanzapine in stable psychiatric subjectsMalcolm Mitchell, Robert Riesenberg, Mohammad A Bari, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Diabetes, Obesity & Metabolism|October 1, 2021
Ultra rapid lispro (URLi) shows accelerated pharmacokinetics and greater reduction in postprandial glucose versus Humalog® in patients with type 1 diabetes mellitus in a randomized, double-blind meal test early-phase studyChristof Kazda, Jennifer Leohr, Rong Liu, et al.
Therapeutic Advances in Neurological Disorders|September 18, 2023
A 20-year multicentre retrospective review of optic nerve sheath fenestration outcomesShaddy El-Masri, Matthew Wilson, Jonathan Goh, et al.
American Journal of Obstetrics & Gynecology MFM|July 12, 2022
Latency of late preterm steroid administration to delivery and risk of neonatal hypoglycemiaEliza R McElwee, Kyla Wilkinson, Rebecca Crowe, et al.
Orbit (Amsterdam, Netherlands)|August 12, 2025
Orbital abscess secondary to acute dacryocystitisJosefina Herrera, Sophia Moshegov, Deepaysh Charanjeet, et al.
Diabetes, Obesity & Metabolism|March 9, 2021
Improved postprandial glucose control with ultra rapid lispro versus lispro with continuous subcutaneous insulin infusion in type 1 diabetes: PRONTO-Pump-2Mark Warren, Bruce Bode, Jang I Cho, et al.
Sensors (Basel, Switzerland)|July 12, 2025
Wavelet-Based P-Wave Detection in High-Rate GNSS Data: A Novel Approach for Rapid Earthquake Monitoring in Tsunamigenic SettingsAjat Sudrajat, Irwan Meilano, Hasanuddin Z Abidin, et al.
Children (Basel, Switzerland)|October 23, 2021
Dexamethasone Alters Tracheal Aspirate T-Cell Cytokine Production in Ventilated Preterm InfantsSiamak M Yazdi, Ekta U Patel, Colby D Richardson, et al.
Diabetes, Obesity & Metabolism|October 10, 2023
Ultra rapid lispro (Lyumjev®) shortens time to recovery from hyperglycaemia compared to Humalog® in individuals with type 1 diabetes on continuous subcutaneous insulin infusionJennifer Leohr, Mary Anne Dellva, Elizabeth LaBell, et al.
Diabetes, Obesity & Metabolism|October 4, 2021
Ultra-rapid lispro shows faster pharmacokinetics and reduces postprandial glucose excursions versus Humalog® in patients with type 2 diabetes mellitus in a randomized, controlled crossover meal test early phase studyJennifer Leohr, Christof Kazda, Rong Liu, et al.
Clinical Therapeutics|July 25, 2006
A double-blind, randomized trial to evaluate the pharmacokinetics and tolerability of 30 or 40 mg/d oral olanzapine relative to 20 mg/d oral olanzapine in stable psychiatric subjectsMalcolm Mitchell, Robert Riesenberg, Mohammad A Bari, et al.
Pageof 5